D. Galanakis

D. Galanakis, M. Bellone, L. Senzel, 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy

D. Galanakis, W. Miesbach, I. Scharrer, 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Thrombosis-associated antifibrinogen IgG1 &kgr; impairs fibrin polymerization and enhances platelet activation

J. Weisel, P. Perrotta, Roy E. Smith, 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Albumin modulates lateral assembly of fibrin polymers: evidence of enhanced fine fibril formation and of unique synergism with fibrinogen.

D. Galanakis, B. Lane, S. Simon, 1987, Biochemistry.

Cigarette smoke contains anticoagulants against fibrin aggregation and factor XIIIa in plasma.

D. Galanakis, P. Laurent, A. Janoff, 1982, Science.

Fibrinogen induces neural stem cell differentiation into astrocytes in the subventricular zone via BMP signaling

S. Schildge, C. Bohrer, C. Schachtrup, 2020, Nature Communications.

Conformational Flexibility and Self-Association of Fibrinogen in Concentrated Solutions.

J. Weisel, A. Zhmurov, V. Barsegov, 2017, The journal of physical chemistry. B.

Human fibrinogen heterogeneities. Preparation and characterization of γ and γ′ chains

D. Galanakis, M. Mosesson, D. Ménaché, 1978 .

Human fibrinogen heterogeneities: distribution and charge characteristics of chains of A alpha origin.

D. Galanakis, M. Mosesson, N. Stathakis, 1978, The Journal of laboratory and clinical medicine.

Anticoagulant albumin fragments that bind to fibrinogen/fibrin: possible implications.

D. Galanakis, 1992, Seminars in thrombosis and hemostasis.

Inherited Dysfibrinogenemia: Emerging Abnormal Structure Associations With Pathologic and Nonpathologic Dysfunctions

D. Galanakis, 1993, Seminars in thrombosis and hemostasis.

Fibrinogen Stony Brook, a heterozygous A alpha 16Arg----Cys dysfibrinogenemia. Evaluation of diminished platelet aggregation support and of enhanced inhibition of fibrin assembly.

A. Henschen, D. Galanakis, E. Peerschke, 1989, The Journal of clinical investigation.

Correction of the Delayed Fibrin Aggregation of Fetal Fibrinogen by Partial Removal of Sialic Acid

D. Galanakis, M. Mosesson, 1979, Thrombosis and Haemostasis.

Homophenotypic Aα R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release

J. Weisel, A. Henschen, D. Galanakis, 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Unusual A alpha 16Arg-->Cys dysfibrinogenaemic family: absence of normal A alpha-chains in fibrinogen from two of four heterozygous siblings.

D. Galanakis, I. Scharrer, S. Spitzer, 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Fibrinogen Triggers Astrocyte Scar Formation by Promoting the Availability of Active TGF-β after Vascular Damage

C. Schachtrup, J. Ryu, K. Akassoglou, 2010, The Journal of Neuroscience.

The essential covalent structure of human fibrinogen evinced by analysis of derivatives formed during plasmic hydrolysis.

J. Finlayson, D. Galanakis, M. Mosesson, 1973, The Journal of biological chemistry.

The synthetic RGDS peptide inhibits the binding of fibrinogen lacking intact alpha chain carboxyterminal sequences to human blood platelets.

D. Galanakis, E. Peerschke, 1987, Blood.

HUMAN FETAL FIBRINOGEN: ITS CHARACTERISTICS OF DELAYED FIBRIN FORMATION, HIGH SIALIC ACID AND AP PEPTIDE CONTENT ARE MORE MARKED IN PRE‐TERM THAN IN TERM SAMPLES

C. McDevitt, D. Galanakis, F. Miller, 1983 .

Mutations on Fibrinogen (γ316–322) Are Associated with Reduction in Platelet Adhesion Under Flow Conditions

J. Sixma, S. Lord, D. Galanakis, 2001 .

A Functional Assay Suggests that Heterodimers Exist in Two C-Terminal γ-Chain Dysfibrinogens: Matsumoto I and Vlissingen/Frankfurt IV

S. Lord, D. Galanakis, F. Terasawa, 2000, Thrombosis and Haemostasis.

FIBRINOGEN LOUISVILLE: AN Aα16 ARG→HIS DEFECT THAT FORMS NO HYBRID MOLECULES IN HETEROZYGOUS INDIVIDUALS AND INHIBITS AGGREGATION OF NORMAL FIBRIN MONOMERS *

A. Henschen, D. Galanakis, E. Peerschke, 1983 .

Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.

D. Galanakis, E. Peerschke, 1983, The Journal of laboratory and clinical medicine.

B:b knob-hole interactions Polymerization of fibrin: direct observation and quantification of individual

J. Weisel, R. Litvinov, D. Galanakis, 2013 .

Fibrin and Collagen Differentially Regulate Human Dermal Microvascular Endothelial Cell Integrins: Stabilization of αv/β3 mRNA by Fibrin1

R. Clark, D. Galanakis, M. Tonnesen, 1999 .

Comparison of human plasma fibrinogen subfractions and early plasmic fibrinogen derivatives.

J. Finlayson, D. Galanakis, M. Mosesson, 1974, The Journal of biological chemistry.

Autologous whole plasma fibrin gel. Intraoperative procurement.

D. Galanakis, A. Hartman, A. Hartman, 1992, Archives of surgery.

Randomized controlled trial of 7, 28, vs 42 day stored red blood cell transfusion on oxygen delivery (VO2 max) and exercise duration

R. Moon, D. Triulzi, Russell Rozensky, 2020, Transfusion.

Another fibrin αC scene unmasked

D. Galanakis, 2005 .

Case report: treatment of an intracranial arteriovenous malformation in a patient with complicated hemophilia.

B. Andrews, D. Galanakis, L. Gerson, 1994, The American journal of the medical sciences.

59. Screening of adult and fetal human fibrinogen with matrix-assisted laser-desorption ionization time-of-flight (MALDI-TOF) mass spectrometry

A. Henschen-Edman, D. Galanakis, V. H. Cao, 1998 .